These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30701442)

  • 1. The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer.
    Reed M; Patrick C; Croft B; Walde N; Voutsadakis IA
    Indian J Gastroenterol; 2019 Feb; 38(1):15-22. PubMed ID: 30701442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients.
    Croft B; Reed M; Patrick C; Kovacevich N; Voutsadakis IA
    J Gastrointest Cancer; 2019 Jun; 50(2):221-229. PubMed ID: 29335847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of metabolic syndrome and prognosis of renal cell cancer.
    Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
    Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City.
    Tang X; Liu Q
    BMC Public Health; 2018 Jun; 18(1):707. PubMed ID: 29879952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes.
    Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
    Clin Exp Nephrol; 2018 Dec; 22(6):1387-1394. PubMed ID: 29934666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease risks of childhood obesity in China.
    Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
    Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007.
    Zhang L; Zhang WH; Zhang L; Wang PY
    Obes Facts; 2011; 4(4):284-9. PubMed ID: 21921651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
    Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
    Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of metabolic syndrome components in patients with acute coronary syndromes].
    Zaliūnas R; Slapikas R; Luksiene D; Slapikiene B; Statkeviciene A; Milvidaite I; Gustiene O
    Medicina (Kaunas); 2008; 44(3):182-8. PubMed ID: 18413984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer.
    Yang X; Li X; Dong Y; Fan Y; Cheng Y; Zhai L; Zhang S; Zhou J; Wang J
    Front Endocrinol (Lausanne); 2021; 12():780769. PubMed ID: 34975754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
    Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
    BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China.
    Liang Y; Zhang C; Luo J; He Y; Zhang Y; Quan Z; Yang L
    Urol Oncol; 2023 May; 41(5):257.e19-257.e26. PubMed ID: 36967252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS).
    Bagheri P; Khalil D; Seif M; Khedmati Morasae E; Bahramali E; Azizi F; Rezaianzadeh A
    Diabetes Metab Syndr; 2021; 15(1):99-108. PubMed ID: 33321311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status.
    Siena S; Rivera F; Taieb J; Peeters M; Prenen H; Koukakis R; Demonty G; Köhne CH
    Clin Colorectal Cancer; 2018 Mar; 17(1):50-57.e8. PubMed ID: 29096990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study.
    Shehaj I; Krajnak S; Rad MT; Gasimli B; Hasenburg A; Karn T; Schmidt M; Müller V; Becker S; Gasimli K
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):174. PubMed ID: 38570343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of the metabolic syndrome with target organ damage: focus on the heart, brain, and central arteries.
    Saeed S; Waje-Andreassen U; Nilsson PM
    Expert Rev Cardiovasc Ther; 2020 Sep; 18(9):601-614. PubMed ID: 32757786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
    You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
    Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.